Cargando…
Homozygous mutation of the LRRK2 ROC domain as a novel genetic model of parkinsonism
BACKGROUND: Parkinson’s disease (PD) is one of the most important neurodegenerative disorders in elderly people. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are found in a large proportion of the patients with sporadic and familial PD. Mutations can occur at different locations in the...
Autores principales: | Chen, Meng-Ling, Wu, Ruey-Meei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375908/ https://www.ncbi.nlm.nih.gov/pubmed/35965315 http://dx.doi.org/10.1186/s12929-022-00844-9 |
Ejemplares similares
-
LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson’s disease: a review
por: Chen, Meng-Ling, et al.
Publicado: (2018) -
Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutations
por: Rudi, Katharina, et al.
Publicado: (2015) -
Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways
por: Sancho, Rosa M., et al.
Publicado: (2009) -
Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations
por: Godena, Vinay K., et al.
Publicado: (2014) -
Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent Dimerization-Based Activation of LRRK2 ROC Domain
por: Li, Xinyi, et al.
Publicado: (2021)